Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)

Cullinan Therapeutics Inc. · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
nasopharyngeal carcinoma, nasopharyngeal cancer, epstein-barr virus, npc, ebv, ebna1 inhibitor, vk-2019, nasopharynx cancer, nasopharynx carcinoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 906216
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.